New Drug Application

Drugs magnifying glass drug inspection FDA inspection FDA review
Pharma

FDA cuts could put agency's user fee programs at risk: reports

Massive cuts at the FDA have hit staff tied to drug reviews and user fees, putting future approvals in jeopardy, according to multiple reports.
Fraiser Kansteiner Apr 4, 2025 11:00am
10 in chalk

Tenpoint preps FDA filing after scoring in presbyopia study

Jan 9, 2025 3:39pm
FDA clipboard

Regulatory tracker: Bayer adds new Kerendia CV outcomes nod

Aug 29, 2022 9:48am
FDA

CorMedix hit with another CRL in effort to get nod for DefenCath

Aug 9, 2022 10:00am